Triomune 30+150+200mg
Available Dosages
| SKU | 1029 |
|---|---|
| Generic For | Triomune |
| Strength | 30+150+200mg |
| Active Ingredient | Stavudine+Lamivudine+Nevirapine |
Out Of Stock
Triomune 30+150+200mg (Stavudine+Lamivudine+Nevirapine) for HIV Treatment
Triomune 30 mg/150 mg/200 mg (Stavudine)
Triomune is an antiretroviral medication used in the management of HIV. It is recommended for HIV-infected adults. The medicine lowers the amount of HIV in the blood and keeps it at a low level. It plays a significant role in maintaining a healthy immune system to help fight infection. It is a combination drug containing three active components lamivudine, nevirapine, and stavudine. Lamivudine and stavudine belongs to the group of medicines known as nucleoside analogue. Nevirapine, the third active component of the medicine is a non-nucleoside reverse transcriptase inhibitor.
What is Triomune used for?
Triomune is used to slow down the progression of HIV infection. Its administration allows the number of CD4 cells to increase and to help the defense system to recover and reduce the risk of spreading the disease.
How does Triomune work?
Both stavudine and lamivudine belong to the group of medication known as nucleoside analogs. Both antiretroviral agents work together by terminating the growth of the DNA chain and reverse transcriptase of HIV. On the other hand, nevirapine is a non-nucleoside reverse transcriptase inhibitor. It functions by directly inhibiting reverse transcriptase.
What does Triomune contain?
Each Triomune tablet contains half of the commonly prescribed daily doses of lamivudine, stavudine, and nevirapine.
Where to buy Triomune online?
Triomune is available for oral administration in the form of tablets. It is avaialbel in the pack sizes of 30, 60, and 90. You can buy Triomune 30+150+200 mg online from our website premiumrxdrugs.com at a quite affordable price.
What are the side effects of Triomune?
Tell your physician if you experience any of the following unwanted effects:
- Vomiting
- Abdominal pain
- Diarrhea
- Muscle pain
- Fever
- Malaise
- Nausea
- Cough
- Rash
- Neutropenia and anemia
- Paronychia
- Urticaria
- Thrombocytopenia
- Rarely rhabdomyolysis
- Hepatitis
- Alopecia
- Increases in LFTs
- Angioedema
- Pancreatitis
- Peripheral neuropathy
- Arthralgia
- HeadacheAnaphylactoid reaction
- Lactic acidosis associated with severe hepatomegaly and hepatic steatosis
Get immediate medical help if any of the above mentined side effects become troublesome.
What medications interact with Triomune?
Some medications can interact negatively with Triomune 30힝㻛䴦�, which can affect Triomune’s mode of action. Drugs that should not be taken with Triomune are as follows:
- Doxorubicin
- Methadone
- Sulfamethoxazole
- Ribavirin
- Ketoconazole
- Oral contraceptives
- Trimethoprim
- Other antiretroviral agents like indinavir, saquinavir, lopinavir, efavirenz, etc.
- Rifampin
When should Triomune not be taken?
- The medicine should not be taken if you have received previous treatment for HIV infection and specific treatment with Nevirapine.
- Avoid taking it if you have renal disorders.
- It is not safe to consume during pregnancy and lactation.
- If you have previously experienced peripheral neuropathy then do not take this combination formulation.
- It’s use is contraindicated in patients who are just starting treatment with nevirapine.
- The drugs should not be given to patients who have been demonstrated hypersensitivity to any of the components present in the preparation.
How should Triomune be taken?
The medicine should be administered two times a day, permitting a fixed dose combination to be formulated. Take it with a glass full of water as prescribed by your physician.
How long should you take Triomune?
Take the combination drug as long as it is recommended to you. The medicine will not cure the infection; it controls the spreading of HIV in the patient’s body.
Missed dose of Triomune
Always remember to take the dose of Triomune on time. If you miss a dose, then take it as soon as you remember. If it is time for the next scheduled dose, then avoid taking it with a second dose.
How should Triomune be stored?
Keep it out of the reach of children and away from pets. Don’t freeze the tablets. Store it at room temperature.
What is Triomune 30/150/200mg used for?
Triomune 30/150/200mg contains stavudine 30mg, lamivudine 150mg, and nevirapine 200mg — a triple fixed-dose combination antiretroviral (FDC) that delivers a complete three-drug HIV treatment regimen in one tablet twice daily. This all-in-one FDC simplifies HIV therapy and improves adherence — a major factor in the success of antiretroviral programmes. Triomune was widely deployed in resource-limited HIV treatment programmes globally, particularly in Africa and South Asia, as a cost-effective generic FDC. However, its use is now declining as stavudine (d4T) is being phased out due to serious long-term toxicity.
Why is stavudine in Triomune 30 associated with long-term toxicity?
Stavudine (d4T) causes significant mitochondrial toxicity through inhibition of mitochondrial DNA polymerase gamma — more so than other NRTIs. Long-term stavudine use causes: lipoatrophy (irreversible fat loss in the face, limbs, and buttocks — a disfiguring complication), peripheral neuropathy (numbness, tingling, burning pain in the feet and legs), and lactic acidosis (potentially fatal mitochondrial failure). These complications develop after months to years of therapy. WHO 2013 and subsequent guidelines recommend replacing stavudine with tenofovir or zidovudine in all new initiations. Patients currently on Triomune should discuss transition to a d4T-free regimen with their HIV clinician.
How should Triomune 30/150/200mg be taken?
Triomune is taken as one tablet twice daily (morning and evening, 12 hours apart). It can be taken with or without food. The nevirapine component requires a 14-day lead-in period: initiate with nevirapine 200mg once daily (not twice daily) for 14 days — this typically requires separate nevirapine and NRTI tablets for the lead-in before transitioning to the FDC. After the lead-in, Triomune twice daily provides the complete triple regimen. Maintain >95% adherence — even occasional missed doses risk viral rebound and resistance development, particularly given nevirapine's low genetic resistance barrier.
What should patients switching from Triomune to safer regimens know?
Switching from Triomune (d4T-containing) to d4T-free regimens is strongly recommended by WHO and HIV treatment guidelines. Preferred switch options: tenofovir + lamivudine + nevirapine (or EFV) FDC (e.g. TLE) — replacing stavudine with tenofovir while retaining lamivudine and NNRTI; or transition to dolutegravir-based regimen. The switch should be virologically guided — if viral load is undetectable, drug-sensitive switch is appropriate. Lipoatrophy from past d4T use does not fully reverse after switching — facial lipoatrophy can persist years after stopping stavudine. Peripheral neuropathy may stabilise or partially improve after switch. Genotypic resistance testing before switch identifies whether accumulated resistance affects options.
What nevirapine-related monitoring applies to Triomune 30?
The nevirapine component of Triomune carries the same hepatotoxicity and rash risk as standalone nevirapine. LFT monitoring: baseline, weeks 2, 4, 8, 12, then 3-monthly for the first 18 weeks. CD4 restrictions apply: do not initiate in women CD4 >250 or men CD4 >400. Educate patients about hepatitis symptoms (jaundice, dark urine, fatigue, abdominal pain) and rash — stop immediately if these develop. Severe rash or symptomatic hepatitis: stop all antiretrovirals simultaneously — stopping one drug in a combination risks functional NRTI monotherapy and resistance. Do not rechallenge with nevirapine after severe reactions.
Is Triomune 30 safe in patients with peripheral neuropathy?
Stavudine (d4T) is a leading cause of peripheral neuropathy in HIV patients — causing dose-dependent axonal neuropathy that can be severe and disabling. If a patient already has peripheral neuropathy (from HIV itself, other medications, or diabetes), adding stavudine in Triomune significantly worsens neuropathy risk. In patients with pre-existing neuropathy, stavudine-containing regimens including Triomune 30 should be avoided — switch to tenofovir-based FDCs. Established d4T-induced neuropathy: switch regimen immediately; neuropathy may stabilise or slowly improve after stopping stavudine, but severe neuropathy may be irreversible. Pain management (amitriptyline, gabapentin, pregabalin) alongside regimen switch.
What drug interactions affect Triomune 30?
Nevirapine component's CYP3A4 induction dominates: reduces PI, rifampicin, hormonal contraceptive levels (use non-hormonal contraception). Stavudine: ribavirin antagonises d4T's antiviral activity; methotrexate competes for renal excretion. Lamivudine: emtricitabine duplicates mechanism — never combine; trimethoprim increases lamivudine levels. The complexity of managing interactions with three-drug combinations makes specialist HIV pharmacist review essential before adding any new medication to a Triomune regimen.
Is Triomune equivalent to the sum of its component drugs?
Triomune provides pharmacokinetically equivalent exposure to separately administered stavudine 30mg + lamivudine 150mg + nevirapine 200mg. Bioequivalence studies confirm the FDC achieves the same plasma drug levels as individual tablets — enabling the convenience of one tablet twice daily without sacrificing antiviral efficacy. The simplification from multiple tablets to one FDC has been shown to improve adherence, which directly translates to better viral suppression and reduced resistance risk.
Can I order Triomune 30 from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Triomune 30 to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified HIV antiretrovirals, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international pharmacy for affordable triple HIV therapy.
What side effects should Triomune 30 patients monitor for?
Monitor for: peripheral neuropathy from stavudine (tingling, burning, numbness in feet — report immediately; stop d4T if confirmed d4T neuropathy); lipoatrophy (fat loss in face, limbs — insidious, develops over months; switch regimen when detected); lactic acidosis (abdominal pain, nausea, fatigue, dyspnoea, unexplained weight loss — emergency; stop all antiretrovirals and seek hospital care); nevirapine hepatotoxicity (jaundice, dark urine, right upper quadrant pain — stop all drugs immediately); nevirapine rash (stop at first sign of severe rash with systemic symptoms); anaemia from lamivudine (rare) — FBC monitoring. Annual FBC, LFTs, renal function, and HIV viral load.
Why is Triomune being replaced in modern HIV programmes?
Triomune is being phased out globally for three key reasons: (1) Stavudine's mitochondrial toxicity — lipoatrophy, neuropathy, and lactic acidosis significantly reduce quality of life and life expectancy, especially with long-term use; (2) Nevirapine's hepatotoxicity risk and CD4 restrictions limit its use; (3) Superior alternatives exist — tenofovir + lamivudine + dolutegravir (TLD) FDC achieves better viral suppression (>90% at 48 weeks), better tolerability, higher genetic resistance barrier (dolutegravir), and once-daily dosing. WHO 2019 guidelines designated TLD as the preferred first-line regimen for most adults globally. Patients remaining on Triomune should transition to TLD or another d4T-free, dolutegravir-based regimen.
Login
Sign Up
Login
Sign Up